How Imunexus Therapeutics collects, manages and protects personal information.
This Privacy Policy applies to your use of the website of Imunexus Therapeutics (“Imunexus” or “the Company”) at www.imunexus.com.
Imunexus is committed to protecting the privacy of individuals whose personal information we collect and hold. We handle personal information in accordance with the Australian Privacy Principles set out in the Privacy Act 1988 (Cth).
Imunexus is committed to protecting the privacy of individuals whose personal information we collect and hold. We manage personal information responsibly, securely and transparently in accordance with applicable Australian privacy laws.
This Privacy Policy describes how Imunexus complies with its obligations under the Privacy Act 1988 (Cth), including how personal information is collected, used, disclosed, stored and protected.
“Personal information” means information or an opinion about an identified individual, or an individual who is reasonably identifiable.
The Imunexus website is primarily an informational channel. Imunexus does not collect personal information directly from members of the public through transactional forms, product registrations or consumer accounts on its website.
Imunexus may collect personal information that is reasonably necessary for investor and shareholder communications, recruitment and human resources, corporate operations, stakeholder engagement and related business activities.
This information may include:
Imunexus will only collect sensitive information where permitted or required by law, or where consent has been provided.
This website may use cookies. Cookies are small pieces of data stored on your device browser and are used to improve website functionality, manage traffic and analyse website performance.
The Imunexus website may use:
You may disable cookies through your browser settings, however some website functionality may not operate correctly if cookies are disabled.
This website may contain links to external websites. Imunexus is not responsible for the privacy practices or content of third-party websites.
The Imunexus website may provide the facility for users to subscribe to receive company announcements, investor updates and related communications.
Personal information provided for these purposes will only be used for the purpose for which it was provided, unless consent is given otherwise or disclosure is required by law.
Imunexus may use personal information to send investor updates, market announcements, event invitations and communications relating to the Company and its activities.
Individuals may opt out of receiving direct marketing communications at any time by using the unsubscribe functionality or by contacting Imunexus directly.
Imunexus does not sell personal information.
Imunexus may disclose personal information to overseas service providers, including cloud hosting, email and IT service providers located in jurisdictions such as the United States and the European Union.
Imunexus takes reasonable steps to ensure overseas recipients manage personal information in a manner consistent with the Australian Privacy Principles.
Imunexus takes reasonable steps to protect personal information from misuse, interference, loss, unauthorised access, modification or disclosure.
Security measures may include:
Imunexus retains personal information only for as long as required for lawful business or regulatory purposes. Information that is no longer required is securely destroyed or de-identified where appropriate.
Imunexus will only use personal information for the purpose for which it was provided, unless consent has been obtained or disclosure is otherwise required or authorised by law.
Personal information may be used or disclosed where:
Imunexus takes reasonable steps to ensure that personal information is accurate, current, complete and relevant.
Individuals may request access to personal information held by Imunexus or request corrections to inaccurate information by contacting the Privacy Officer.
Imunexus may decline requests in limited circumstances permitted under the Privacy Act 1988 (Cth).
If an individual believes Imunexus has breached the Australian Privacy Principles or this Privacy Policy, they may submit a complaint to the Imunexus Privacy Officer.
If the complaint is not resolved satisfactorily, individuals may contact the Office of the Australian Information Commissioner (OAIC).
Imunexus Therapeutics Limited
La Trobe University
LIMS2 Building
Science Drive, Bundoora VIC 3086
Email: info@imunexus.com
This Privacy Policy was last reviewed and approved on 11 May 2026.